PURPOSE: Pediatricians will play a critical role in human papillomavirus (HPV) vaccine delivery. The objectives of this research were to examine pediatricians' views about key issues related to HPV vaccine delivery and identify their strategies for effective vaccine delivery. METHODS: A diverse sample of practicing pediatricians was recruited from a three-state region using a purposeful sampling strategy. Participants completed in-depth, semi-structured interviews. Qualitative data were analyzed using framework analysis. RESULTS: The mean age of the 31 participants was 47 years (range 30-78 years), and 17 (55%) were female. In all, 18 were white, nine (29%) black, and four (13%) Latino. Participants noted that cultural issues, including a family's religious and ethnic background, were important considerations when recommending an HPV vaccine. Almost all participants believed that vaccination should be universal rather than targeted, but opinions regarding legislative mandates for vaccination varied. Those in favor of mandates cited their potential to maximize the public health impact of immunization, while those opposed noted that HPV is not transmitted casually and were concerned about limited data on the long-term safety and efficacy of HPV vaccines. Pediatricians noted that specific strategies for effective vaccine delivery would be needed for an STI vaccine targeted toward adolescents, especially considering the poor public understanding of HPV. These included provision of HPV vaccines in alternative settings, guidance for pediatricians as to how to address parental concerns, and specific educational initiatives. CONCLUSIONS: The views of pediatricians, who have extensive experience administering vaccines to children and adolescents, will be valuable as HPV vaccine delivery strategies are designed.
PURPOSE: Pediatricians will play a critical role in human papillomavirus (HPV) vaccine delivery. The objectives of this research were to examine pediatricians' views about key issues related to HPV vaccine delivery and identify their strategies for effective vaccine delivery. METHODS: A diverse sample of practicing pediatricians was recruited from a three-state region using a purposeful sampling strategy. Participants completed in-depth, semi-structured interviews. Qualitative data were analyzed using framework analysis. RESULTS: The mean age of the 31 participants was 47 years (range 30-78 years), and 17 (55%) were female. In all, 18 were white, nine (29%) black, and four (13%) Latino. Participants noted that cultural issues, including a family's religious and ethnic background, were important considerations when recommending an HPV vaccine. Almost all participants believed that vaccination should be universal rather than targeted, but opinions regarding legislative mandates for vaccination varied. Those in favor of mandates cited their potential to maximize the public health impact of immunization, while those opposed noted that HPV is not transmitted casually and were concerned about limited data on the long-term safety and efficacy of HPV vaccines. Pediatricians noted that specific strategies for effective vaccine delivery would be needed for an STI vaccine targeted toward adolescents, especially considering the poor public understanding of HPV. These included provision of HPV vaccines in alternative settings, guidance for pediatricians as to how to address parental concerns, and specific educational initiatives. CONCLUSIONS: The views of pediatricians, who have extensive experience administering vaccines to children and adolescents, will be valuable as HPV vaccine delivery strategies are designed.
Authors: Matthew F Daley; Nicole Liddon; Lori A Crane; Brenda L Beaty; Jennifer Barrow; Christine Babbel; Lauri E Markowitz; Eileen F Dunne; Shannon Stokley; L Miriam Dickinson; Stephen Berman; Allison Kempe Journal: Pediatrics Date: 2006-12 Impact factor: 7.124
Authors: Luisa L Villa; Ronaldo L R Costa; Carlos A Petta; Rosires P Andrade; Kevin A Ault; Anna R Giuliano; Cosette M Wheeler; Laura A Koutsky; Christian Malm; Matti Lehtinen; Finn Egil Skjeldestad; Sven-Eric Olsson; Margareta Steinwall; Darron R Brown; Robert J Kurman; Brigitte M Ronnett; Mark H Stoler; Alex Ferenczy; Diane M Harper; Gretchen M Tamms; Jimmy Yu; Lisa Lupinacci; Radha Railkar; Frank J Taddeo; Kathrin U Jansen; Mark T Esser; Heather L Sings; Alfred J Saah; Eliav Barr Journal: Lancet Oncol Date: 2005-05 Impact factor: 41.316
Authors: Lauri E Markowitz; Eileen F Dunne; Mona Saraiya; Herschel W Lawson; Harrell Chesson; Elizabeth R Unger Journal: MMWR Recomm Rep Date: 2007-03-23
Authors: Radmila Prislin; Mark H Sawyer; Michelle De Guire; Jesse Brennan; Kathy Holcomb; Philip R Nader Journal: Am J Prev Med Date: 2002-04 Impact factor: 5.043
Authors: Brendan Flannery; Stephanie Schrag; Nancy M Bennett; Ruth Lynfield; Lee H Harrison; Arthur Reingold; Paul R Cieslak; James Hadler; Monica M Farley; Richard R Facklam; Elizabeth R Zell; Cynthia G Whitney Journal: JAMA Date: 2004-05-12 Impact factor: 56.272
Authors: Xiaoli Nan; Kelly Daily; Adam Richards; Cheryl Holt; Min Qi Wang; Kate Tracy; Yan Qin Journal: Hum Vaccin Immunother Date: 2018-11-05 Impact factor: 3.452
Authors: Albert J Farias; Lara S Savas; Maria E Fernandez; Sharon P Coan; Ross Shegog; C Mary Healy; Erica Lipizzi; Sally W Vernon Journal: Prev Med Date: 2017-08-20 Impact factor: 4.018
Authors: Kristen A Feemster; Maria Middleton; Alexander G Fiks; Sarah Winters; Sara B Kinsman; Jessica A Kahn Journal: Hum Vaccin Immunother Date: 2014-10-30 Impact factor: 3.452